ABBOTT PARK, Ill., Jan. 30, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that its Tendyne™ Transcatheter Mitral Valve Implantation (TMVI) system received CE Mark and is now approved for use ...

ABBOTT PARK, Ill., Jan. 30, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that its Tendyne™ Transcatheter Mitral Valve Implantation (TMVI) system received CE Mark and is now approved for use ...

LUXEMBOURG / ACCESSWIRE / February 3, 2020 / Jean Boulle Medtech Ltd. (the "Company"), founder of Tendyne Holdings, Inc. ("Tendyne") and a Jean Boulle Group (the "Group") company developing medical ...

The Tendyne system replaces mitral valves that are not functioning properly due to a buildup of calcium in the base of the valves, known as severe mitral annular calcification (MAC) Tendyne offers a ...

ABBOTT PARK, Ill., Jan. 30, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that its Tendyne™ Transcatheter Mitral Valve Implantation (TMVI) system received CE Mark and is now approved for use ...

- First-of-its-kind technology addresses critical need to eliminate mitral regurgitation when surgery or mitral repair is not an option As the most common heart disease affecting the heart valves, MR ...

The Tendyne system replaces mitral valves that are not functioning properly due to a buildup of calcium in the base of the valves, known as severe mitral annular calcification (MAC) Tendyne offers a ...

LUXEMBOURG--(BUSINESS WIRE)--Jean Boulle Medtech Ltd, a Jean Boulle Group (www.jeanboullegroup.com) medical technology company and founding investor of Tendyne Holdings, Inc. ("Tendyne"), is pleased ...

Two-year outcomes following transcatheter mitral valve replacement with the Tendyne prosthesis showed durable control of mitral regurgitation, sustained improvement in quality of life and functional ...

Abbott announced the US Food and Drug Administration (FDA) has approved the company's Tendyne transcatheter mitral valve replacement (TMVR) system to treat people with mitral valve disease. This ...

Minneapolis Heart Institute Foundation is the first research center in the USA to report implant of a TMVR Device ROSEVILLE, Minn., Tendyne Holdings, Inc. ("Tendyne") a privately held clinical stage ...